Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05863052
What this trial is testing

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Who this might be right for
Immune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more
University of Oklahoma 72
Testing effectiveness (Phase 2)Study completedNCT03015740
What this trial is testing

Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00021021
What this trial is testing

RPI.4610 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Ribozyome
Early research (Phase 1)Study completedNCT03063762
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776717
What this trial is testing

TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT02697591
What this trial is testing

INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 100
Early research (Phase 1)Study completedNCT00715182
What this trial is testing

A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer

Who this might be right for
Advanced/ Metastatic Renal Cell Cancer
Novartis Pharmaceuticals 87
Testing effectiveness (Phase 2)Ended earlyNCT02581384
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors

Who this might be right for
Ewing SarcomaRhabdomyosarcomaWilms Tumor+8 more
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT02781506
What this trial is testing

Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
University of Texas Southwestern Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT00030342
What this trial is testing

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center 60
Early research (Phase 1)Study completedNCT01352962
What this trial is testing

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00006486
What this trial is testing

Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 335
Post-approval studies (Phase 4)Study completedNCT05293041
What this trial is testing

Argipressin's Influence on Blood Loss During Hepatic Resection

Who this might be right for
Colon Cancer Liver MetastasisInflammatory ResponseVasopressin Causing Adverse Effects in Therapeutic Use
Kristina Svennerholm 248
Early research (Phase 1)Looking for participantsNCT07300241
What this trial is testing

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more
Neomorph, Inc 30
Not applicableStudy completedNCT04006405
What this trial is testing

AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Elypta 280
Testing effectiveness (Phase 2)Study completedNCT03581773
What this trial is testing

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

Who this might be right for
MucositisStomatitis
Niels Fristrup 84
Testing effectiveness (Phase 2)Study completedNCT03149822
What this trial is testing

Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Colorado, Denver 45
Testing effectiveness (Phase 2)Study completedNCT00005831
What this trial is testing

Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+3 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01510119
What this trial is testing

Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 40
Testing effectiveness (Phase 2)Looking for participantsNCT07223541
What this trial is testing

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
University of Oklahoma 72
Next Page